54.40INR
246.07 MINR
1.37 BINR
2.15 M
About JENBURKT PHARMACEUTICALS LTD.
Sector
CEO
Ashish Uttam Bhuta
Headquarters
Mumbai
Website
Employees (FY)
724
Founded
1985
ISIN
INE354A01013
FIGI
BBG000BHLXD9
Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The firm offers anthelmintic, anti-osteoporotic, anti-arthritic, anti-ulcerants, antibiotics, aphrodisiac, anti-cough, and cold and allergy dermatological products. The company was founded by Hemendra N. Bhuta, Uttambhai Nandlal Bhuta and Harshad N. Bhuta on June 10, 1985, and is headquartered in Mumbai, India.
Jenburkt Pharma: Long Term Strategy- Suitable for InvestorsJenburkt Pharma: Long Term Strategy Suitable for Investors
The stock is currently in reversal mode. Will show uptrend in coming days. May consider this stock for long duration.
Disclaimer: It is not my recommendation and it is only my view on this stock. Research and consult with your financial advi
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of JENBURPH is 734.85 INR — it has decreased by 0.31% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange JENBURKT PHARMACEUTICALS LTD. stocks are traded under the ticker JENBURPH.
JENBURKT PHARMACEUTICALS LTD. is going to release the next earnings report on May 28, 2024. Keep track of upcoming events with our Earnings Calendar.
JENBURPH stock is 2.88% volatile and has beta coefficient of 0.64. Check out the list of the most volatile stocks — is JENBURKT PHARMACEUTICALS LTD. there?
Yes, you can track JENBURKT PHARMACEUTICALS LTD. financials in yearly and quarterly reports right on TradingView.
JENBURPH stock has fallen by 0.70% compared to the previous week, the month change is a 4.60% rise, over the last year JENBURKT PHARMACEUTICALS LTD. has showed a 3.95% increase.
JENBURPH net income for the last quarter is 54.04 M INR, while the quarter before that showed 73.22 M INR of net income which accounts for −26.19% change. Track more JENBURKT PHARMACEUTICALS LTD. financial stats to get the full picture.
Today JENBURKT PHARMACEUTICALS LTD. has the market capitalization of 3.25 B, it has decreased by 1.34% over the last week.
Yes, JENBURPH dividends are paid annually. The last dividend per share was 14.40 INR. As of today, Dividend Yield (TTM)% is 1.95%. Tracking JENBURKT PHARMACEUTICALS LTD. dividends might help you take more informed decisions.
JENBURKT PHARMACEUTICALS LTD. dividend yield was 2.16% in 2022, and payout ratio reached 25.83%. The year before the numbers were 2.12% and 24.70% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, JENBURPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JENBURKT PHARMACEUTICALS LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 724.00 employees. See our rating of the largest employees — is JENBURKT PHARMACEUTICALS LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JENBURKT PHARMACEUTICALS LTD. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JENBURKT PHARMACEUTICALS LTD. stock shows the buy signal. See more of JENBURKT PHARMACEUTICALS LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JENBURKT PHARMACEUTICALS LTD. EBITDA is 307.65 M INR, and current EBITDA margin is 22.57%. See more stats in JENBURKT PHARMACEUTICALS LTD. financial statements.